FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296044897> ?p ?o ?g. }

• W4296044897 abstract "Background There is growing evidence that chronic obstructive pulmonary disease (COPD) can increase the risk of lung cancer, which poses a serious threat to treatment and management. Therefore, we performed a meta-analysis of lung cancer prevalence in patients with COPD with the aim of providing better prevention and management strategies. Methods We systematically searched PubMed, EMBASE, Web of Science, and Cochrane Library databases from their inception to 20 March 2022 to collect studies on the prevalence of lung cancer in patients with COPD. We evaluated the methodological quality of the included studies using the tool for assessing the risk of bias in prevalence studies. Meta-analysis was used to determine the prevalence and risk factors for lung cancer in COPD. Subgroup and sensitivity analyses were conducted to explore the data heterogeneity. Funnel plots combined with Egger’s test were used to detect the publication biases. Results Thirty-one studies, covering 829,490 individuals, were included to investigate the prevalence of lung cancer in patients with COPD. Pooled analysis demonstrated that the prevalence of lung cancer in patients with COPD was 5.08% (95% confidence interval [CI]: 4.17–6.00%). Subgroup analysis showed that the prevalence was 5.09% (95% CI: 3.48–6.70%) in male and 2.52% (95% CI: 1.57–4.05%) in female. The prevalence of lung cancer in patients with COPD who were current and former smokers was as high as 8.98% (95% CI: 4.61–13.35%) and 3.42% (95% CI: 1.51–5.32%); the incidence rates in patients with moderate and severe COPD were 6.67% (95% CI: 3.20–10.14%) and 5.57% (95% CI: 1.89–16.39%), respectively, which were higher than the 3.89% (95% CI: 2.14–7.06%) estimated in patients with mild COPD. Among the types of lung cancer, adenocarcinoma and squamous cell carcinoma were the most common, with incidence rates of 1.59% (95% CI: 0.23–2.94%) and 1.35% (95% CI: 0.57–3.23%), respectively. There were also differences in regional distribution, with the highest prevalence in the Western Pacific region at 7.78% (95% CI: 5.06–10.5%), followed by the Americas at 3.25% (95% CI: 0.88–5.61%) and Europe at 3.21% (95% CI: 2.36–4.06%). Conclusions This meta-analysis shows that patients with COPD have a higher risk of developing lung cancer than those without COPD. More attention should be given to this result in order to reduce the risk of lung cancer in these patients with appropriate management and prevention. Systematic review registration International prospective register of systematic reviews, identifier CRD42022331872." @default.
• W4296044897 created "2022-09-17" @default.
• W4296044897 creator A5015741830 @default.
• W4296044897 creator A5026720933 @default.
• W4296044897 creator A5033787359 @default.
• W4296044897 creator A5036909733 @default.
• W4296044897 creator A5055224745 @default.
• W4296044897 creator A5082551912 @default.
• W4296044897 date "2022-09-16" @default.
• W4296044897 modified "2023-09-30" @default.
• W4296044897 title "Prevalence of lung cancer in chronic obstructive pulmonary disease: A systematic review and meta-analysis" @default.
• W4296044897 cites W1597426389 @default.
• W4296044897 cites W1646110001 @default.
• W4296044897 cites W1872021546 @default.
• W4296044897 cites W1912936344 @default.
• W4296044897 cites W1916266119 @default.
• W4296044897 cites W1966235050 @default.
• W4296044897 cites W1982158391 @default.
• W4296044897 cites W1982225319 @default.
• W4296044897 cites W1986508764 @default.
• W4296044897 cites W1990738892 @default.
• W4296044897 cites W1996726906 @default.
• W4296044897 cites W2003453766 @default.
• W4296044897 cites W2010549381 @default.
• W4296044897 cites W2018446948 @default.
• W4296044897 cites W2026700673 @default.
• W4296044897 cites W2028173490 @default.
• W4296044897 cites W2050070510 @default.
• W4296044897 cites W2063277639 @default.
• W4296044897 cites W2092923243 @default.
• W4296044897 cites W2098208377 @default.
• W4296044897 cites W2110573194 @default.
• W4296044897 cites W2118262490 @default.
• W4296044897 cites W2132313162 @default.
• W4296044897 cites W2133632534 @default.
• W4296044897 cites W2137397912 @default.
• W4296044897 cites W2139150617 @default.
• W4296044897 cites W2139503178 @default.
• W4296044897 cites W2154583077 @default.
• W4296044897 cites W2166406579 @default.
• W4296044897 cites W2169271662 @default.
• W4296044897 cites W2236401260 @default.
• W4296044897 cites W2334989763 @default.
• W4296044897 cites W2415417288 @default.
• W4296044897 cites W2465104010 @default.
• W4296044897 cites W2492095263 @default.
• W4296044897 cites W2522308674 @default.
• W4296044897 cites W2559067009 @default.
• W4296044897 cites W2586894000 @default.
• W4296044897 cites W2601014492 @default.
• W4296044897 cites W2745140410 @default.
• W4296044897 cites W2746324357 @default.
• W4296044897 cites W2746473595 @default.
• W4296044897 cites W2752625590 @default.
• W4296044897 cites W2763244509 @default.
• W4296044897 cites W2787349298 @default.
• W4296044897 cites W2791385865 @default.
• W4296044897 cites W2801991122 @default.
• W4296044897 cites W2804784400 @default.
• W4296044897 cites W2805582950 @default.
• W4296044897 cites W2889153270 @default.
• W4296044897 cites W2890108380 @default.
• W4296044897 cites W2904845562 @default.
• W4296044897 cites W2914577861 @default.
• W4296044897 cites W2916747909 @default.
• W4296044897 cites W2919861754 @default.
• W4296044897 cites W2919956521 @default.
• W4296044897 cites W2943731098 @default.
• W4296044897 cites W2951663586 @default.
• W4296044897 cites W2953640293 @default.
• W4296044897 cites W2972866244 @default.
• W4296044897 cites W2979726429 @default.
• W4296044897 cites W3014093590 @default.
• W4296044897 cites W3033438356 @default.
• W4296044897 cites W3034544125 @default.
• W4296044897 cites W3090626718 @default.
• W4296044897 cites W3118615836 @default.
• W4296044897 cites W3120355807 @default.
• W4296044897 cites W3125474228 @default.
• W4296044897 cites W3128646645 @default.
• W4296044897 cites W3137556580 @default.
• W4296044897 cites W3183451224 @default.
• W4296044897 cites W4205235474 @default.
• W4296044897 cites W4214606444 @default.
• W4296044897 doi "https://doi.org/10.3389/fonc.2022.947981" @default.
• W4296044897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36185264" @default.
• W4296044897 hasPublicationYear "2022" @default.
• W4296044897 type Work @default.
• W4296044897 citedByCount "1" @default.
• W4296044897 countsByYear W42960448972023 @default.
• W4296044897 crossrefType "journal-article" @default.
• W4296044897 hasAuthorship W4296044897A5015741830 @default.
• W4296044897 hasAuthorship W4296044897A5026720933 @default.
• W4296044897 hasAuthorship W4296044897A5033787359 @default.
• W4296044897 hasAuthorship W4296044897A5036909733 @default.
• W4296044897 hasAuthorship W4296044897A5055224745 @default.
• W4296044897 hasAuthorship W4296044897A5082551912 @default.
• W4296044897 hasBestOaLocation W42960448971 @default.
• W4296044897 hasConcept C121608353 @default.
• W4296044897 hasConcept C126322002 @default.

• next